CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 2, 2014, Pages 372-386

  Ellis, Blake C ^a   Graham, Lloyd D ^a   Molloy, Peter L ^a  

^a CSIRO   (Australia)

Author keywords

Colorectal cancer; CRNDE; IGF1; Insulin; LncRNA; Warburg effect

Indexed keywords

CRNDE RNA; GLUCOSE; INSULIN; LIPID; LONG UNTRANSLATED RNA; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAF PROTEIN; SMALL INTERFERING RNA; SOMATOMEDIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL METABOLISM; COLORECTAL CANCER; COLORECTAL NEOPLASIA DIFFERENTIALLY EXPRESSED GENE; CONTROLLED STUDY; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; INSULIN TREATMENT; LIPID METABOLISM; METABOLIC REGULATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

COLORECTAL CANCER; COLORECTAL NEOPLASIA DIFFERENTIALLY EXPRESSED; CRC; CRNDE; GENOMIC VERTEBRATE CONSERVED IN INTRON 4; GVC-IN4; IGF1; IGF1R; IGF2; INGENUITY PATHWAY ANALYSIS; INSR; INSULIN; INSULIN RECEPTOR; INSULIN-LIKE GROWTH FACTOR 1; INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR; INSULIN-LIKE GROWTH FACTOR 2; IPA; LNCRNA; LONG NON-CODING RNA; MAMMALIAN TARGET OF RAPAMYCIN; MAPK; MITOGEN ACTIVATED PROTEIN KINASE; MTOR; PHOSPHATIDYLINOSITIDE 3-KINASE; PI3K; TCA; TRICARBOXYLIC ACID; WARBURG EFFECT;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LACTATES; METABOLISM; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RAF KINASES; RNA INTERFERENCE; RNA, LONG NONCODING; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRANSCRIPTOME;

EID: 84890182052     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.10.016     Document Type: Article

References (67)

1. Graham L.D., Pedersen S.K., Brown G.S., Ho T., Kassir Z., Moynihan A.T., Vizgoft E.K., Dunne R., Pimlott L., Young G.P., Lapointe L.C., Molloy P.L. Colorectal neoplasia differentially expressed (CRNDE), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas. Genes Cancer 2011, 2:829-840.
2. Zhang X., Sun S., Pu J.K., Tsang A.C., Lee D., Man V.O., Lui W.M., Wong S.T., Leung G.K. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol. Dis. 2012, 48:1-8.
3. Ellis B.C., Molloy P.L., Graham L.D. CRNDE: a long non-coding RNA involved in CanceR, Neurobiology, and DEvelopment. Front. Genet. 2012, 3:270.
4. Khalil A.M., Guttman M., Huarte M., Garber M., Raj A., Rivea Morales D., Thomas K., Presser A., Bernstein B.E., van Oudenaarden A., Regev A., Lander E.S., Rinn J.L. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:11667-11672.
5. Guttman M., Donaghey J., Carey B.W., Garber M., Grenier J.K., Munson G., Young G., Lucas A.B., Ach R., Bruhn L., Yang X., Amit I., Meissner A., Regev A., Rinn J.L., Root D.E., Lander E.S. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 2011, 295-300.
6. Tilgner H., Knowles D.G., Johnson R., Davis C.A., Chakrabortty S., Djebali S., Curado J., Snyder M., Gingeras T.R., Guigo R. Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAs. Genome Res. 2012, 22:1616-1625.
7. Ellis B.C., Kassir Z., Molloy P.L., Graham L.D. "CRNDE, A Novel Non-Coding RNA (ncRNA) Gene With Elevated Expression in Colorectal Neoplasia", in: Human Genome Meeting 2012, P026. Genetics and Genomics in Personalised Medicine, Sydney, Australia.
8. Guil S., Soler M., Portela A., Carrere J., Fonalleras E., Gomez A., Villanueva A., Esteller M. Intronic RNAs mediate EZH2 regulation of epigenetic targets. Nat. Struct. Mol. Biol. 2012, 19:664-670.
9. Siddle K. Signalling by insulin and IGF receptors: supporting acts and new players. J. Mol. Endocrinol. 2011, 47:R1-R10.
10. Wong R.H., Sul H.S. Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective. Curr. Opin. Pharmacol. 2010, 10:684-691.
11. Boucher J., Tseng Y.H., Kahn C.R. Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription. J. Biol. Chem. 2010, 285:17235-17245.
12. Laron Z. Insulin-a growth hormone. Arch. Physiol. Biochem. 2008, 114:11-16.
13. Clemmons D.R. Involvement of insulin-like growth factor-I in the control of glucose homeostasis. Curr. Opin. Pharmacol. 2006, 6:620-625.
14. Simpson H.L., Jackson N.C., Shojaee-Moradie F., Jones R.H., Russell-Jones D.L., Sonksen P.H., Dunger D.B., Umpleby A.M. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes. J. Clin. Endocrinol. Metab. 2004, 89:425-432.
15. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
16. Warburg O. On respiratory impairment in cancer cells. Science 1956, 124:269-270.
17. Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13:472-482.
18. Silviera M.L., Smith B.P., Powell J., Sapienza C. Epigenetic differences in normal colon mucosa of cancer patients suggest altered dietary metabolic pathways. Cancer Prev. Res. (Phila.) 2012, 5:374-384.
19. Xu W., Seok J., Mindrinos M.N., Schweitzer A.C., Jiang H., Wilhelmy J., Clark T.A., Kapur K., Xing Y., Faham M., Storey J.D., Moldawer L.L., Maier R.V., Tompkins R.G., Wong W.H., Davis R.W., Xiao W. Inflammation, P. host response to injury large-scale collaborative research, human transcriptome array for high-throughput clinical studies. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3707-3712.
20. Donohoe C.L., Pidgeon G.P., Lysaght J., Reynolds J.V. Obesity and gastrointestinal cancer. Br. J. Surg. 2010, 97:628-642.
21. Gunter M.J., Leitzmann M.F. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J. Nutr. Biochem. 2006, 17:145-156.
22. Aleksandrova K., Boeing H., Jenab M., Bas Bueno-de-Mesquita H., Jansen E., van Duijnhoven F.J., Fedirko V., Rinaldi S., Romieu I., Riboli E., Romaguera D., Overvad K., Ostergaard J.N., Olsen A., Tjonneland A., Boutron-Ruault M.C., Clavel-Chapelon F., Morois S., Masala G., Agnoli C., Panico S., Tumino R., Vineis P., Kaaks R., Lukanova A., Trichopoulou A., Naska A., Bamia C., Peeters P.H., Rodriguez L., Buckland G., Sanchez M.J., Dorronsoro M., Huerta J.M., Barricarte A., Hallmans G., Palmqvist R., Khaw K.T., Wareham N., Allen N.E., Tsilidis K.K., Pischon T. Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study. Cancer Prev. Res. (Phila.) 2011, 4:1873-1883.
23. Yuhara H., Steinmaus C., Cohen S.E., Corley D.A., Tei Y., Buffler P.A. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?. Am. J. Gastroenterol. 2011, 106:1911-1921.
24. Li G., Barrett E.J., Wang H., Chai W., Liu Z. Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells. Endocrinology 2005, 146:4690-4696.
25. Kwon H.S., Huang B., Unterman T.G., Harris R.A. Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. Diabetes 2004, 53:899-910.
26. Kwon H.S., Harris R.A. Mechanisms responsible for regulation of pyruvate dehydrogenase kinase 4 gene expression. Adv. Enzyme Regul. 2004, 44:109-121.
27. Bamford S., Dawson E., Forbes S., Clements J., Pettett R., Dogan A., Flanagan A., Teague J., Futreal P.A., Stratton M.R., Wooster R. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br. J. Cancer 2004, 91:355-358.
28. Jeong J.Y., Jeoung N.H., Park K.G., Lee I.K. Transcriptional regulation of pyruvate dehydrogenase kinase. Diabetes Metab J 2012, 36:328-335.
29. Grassian A.R., Metallo C.M., Coloff J.L., Stephanopoulos G., Brugge J.S. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes Dev. 2011, 25:1716-1733.
30. McCormick F. Success and failure on the ras pathway. Cancer Biol. Ther. 2007, 6:1654-1659.
31. Rodriguez-Viciana P., Warne P.H., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Waterfield M.D., Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994, 370:527-532.
32. Castellano E., Downward J. RAS interaction with PI3K: more than just another effector pathway. Genes Cancer 2011, 2:261-274.
33. Oikonomou E., Koc M., Sourkova V., Andera L., Pintzas A. Selective BRAFV600E inhibitor PLX4720, requires TRAIL assistance to overcome oncogenic PIK3CA resistance. PLoS One 2011, 6:e21632.
34. Velho S., Oliveira C., Ferreira A., Ferreira A.C., Suriano G., Schwartz S., Duval A., Carneiro F., Machado J.C., Hamelin R., Seruca R. The prevalence of PIK3CA mutations in gastric and colon cancer. Eur. J. Cancer 2005, 41:1649-1654.
35. Parsons D.W., Wang T.L., Samuels Y., Bardelli A., Cummins J.M., DeLong L., Silliman N., Ptak J., Szabo S., Willson J.K., Markowitz S., Kinzler K.W., Vogelstein B., Lengauer C., Velculescu V.E. Colorectal cancer: mutations in a signalling pathway. Nature 2005, 436:792.
36. Oda K., Okada J., Timmerman L., Rodriguez-Viciana P., Stokoe D., Shoji K., Taketani Y., Kuramoto H., Knight Z.A., Shokat K.M., McCormick F. PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation. Cancer Res. 2008, 68:8127-8136.
37. Seok J., Xu W., Gao H., Davis R.W., Xiao W. JETTA: junction and exon toolkits for transcriptome analysis. Bioinformatics 2012, 28:1274-1275.
38. Chang L., Chiang S.H., Saltiel A.R. Insulin signaling and the regulation of glucose transport. Mol. Med. 2004, 10:65-71.
39. Kimura A., Baumann C.A., Chiang S.H., Saltiel A.R. The sorbin homology domain: a motif for the targeting of proteins to lipid rafts. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:9098-9103.
40. Baumann C.A., Ribon V., Kanzaki M., Thurmond D.C., Mora S., Shigematsu S., Bickel P.E., Pessin J.E., Saltiel A.R. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000, 407:202-207.
41. Denis C., Cortinovis C., Terrain B., Viallard V., Paris H., Murat J.C. Activity of enzymes related to carbohydrate metabolism in the HT 29 colon adenocarcinoma cell line and tumor. Int. J. Biochem. 1984, 16:87-91.
42. Gauthier T., Denis-Pouxviel C., Murat J.C. Carbohydrate metabolism in HT29 colon cancer cells cultured in a glucose free medium supplemented with inosine. Int. J. Biochem. 1989, 21:191-196.
43. Ren J.M., Semenkovich C.F., Gulve E.A., Gao J., Holloszy J.O. Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle. J. Biol. Chem. 1994, 269:14396-14401.
44. Michael L.F., Wu Z., Cheatham R.B., Puigserver P., Adelmant G., Lehman J.J., Kelly D.P., Spiegelman B.M. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3820-3825.
45. Herman M.A., Peroni O.D., Villoria J., Schon M.R., Abumrad N.A., Bluher M., Klein S., Kahn B.B. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 2012, 484:333-338.
46. Iizuka K., Bruick R.K., Liang G., Horton J.D., Uyeda K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:7281-7286.
47. Ishii S., Iizuka K., Miller B.C., Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15597-15602.
48. Dentin R., Pegorier J.P., Benhamed F., Foufelle F., Ferre P., Fauveau V., Magnuson M.A., Girard J., Postic C. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J. Biol. Chem. 2004, 279:20314-20326.
49. Ma L., Tsatsos N.G., Towle H.C. Direct role of ChREBP.Mlx in regulating hepatic glucose-responsive genes. J. Biol. Chem. 2005, 280:12019-12027.
50. Pirola L., Bonnafous S., Johnston A.M., Chaussade C., Portis F., Van Obberghen E. Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells. J. Biol. Chem. 2003, 278:15641-15651.
51. Day F.L., Jorissen R.N., Lipton L., Mouradov D., Sakthianandeswaren A., Christie M., Li S., Tsui C., Tie J., Desai J., Xu Z.-Z., Molloy P., Whitehall V., Leggett B.A., Jones I.T., McLaughlin S., Ward R.L., Hawkins N.J., Ruszkiewicz A.R., Moore J., Busam D., Zhao Q., Strausberg RL G.P., OM S. PIK3CA and PTEN gene and exon mutation-specific clinicopathological and molecular associations in colorectal cancer. Clin. Cancer Res. 2013, 19:3285-3296.
52. Hartmann B., Castelo R., Blanchette M., Boue S., Rio D.C., Valcarcel J. Global analysis of alternative splicing regulation by insulin and wingless signaling in Drosophila cells. Genome Biol. 2009, 10:R11.
53. Apostolatos A., Song S., Acosta S., Peart M., Watson J.E., Bickford P., Cooper D.R., Patel N.A. Insulin promotes neuronal survival via the alternatively spliced protein kinase CdeltaII isoform. The Journal of biological chemistry 2012, 287:9299-9310.
54. Jiang K., Patel N.A., Watson J.E., Apostolatos H., Kleiman E., Hanson O., Hagiwara M., Cooper D.R. Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid. Endocrinology 2009, 150:2087-2097.
55. Shabalina S.A., Spiridonov A.N., Spiridonov N.A., Koonin E.V. Connections between alternative transcription and alternative splicing in mammals. Genome Biol. Evol. 2010, 2:791-799.
56. Bhan A., Hussain I., Ansari K.I., Kasiri S., Bashyal A., Mandal S.S. Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol. J. Mol. Biol. 2013, 425:3707-3722.
57. Kogo R., Shimamura T., Mimori K., Kawahara K., Imoto S., Sudo T., Tanaka F., Shibata K., Suzuki A., Komune S., Miyano S., Mori M. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011, 71:6320-6326.
58. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.C., Hung T., Argani P., Rinn J.L., Wang Y., Brzoska P., Kong B., Li R., West R.B., van de Vijver M.J., Sukumar S., Chang H.Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
59. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11:85-95.
60. Lunt S.Y., Vander Heiden M.G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 2011, 27:441-464.
61. Bartrons R., Caro J. Hypoxia, glucose metabolism and the Warburg's effect. J. Bioenerg. Biomembr. 2007, 39:223-229.
62. Roediger W.E. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980, 21:793-798.
63. Roediger W.E. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 1982, 83:424-429.
64. Donohoe D.R., Collins L.B., Wali A., Bigler R., Sun W., Bultman S.J. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 2012, 48:612-626.
65. Donohoe D.R., Garge N., Zhang X., Sun W., O'Connell T.M., Bunger M.K., Bultman S.J. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011, 13:517-526.
66. Taubes G. Cancer research. Unraveling the obesity-cancer connection. Science 2012, 335(28):30-32.
67. Upadhyay M., Samal J., Kandpal M., Singh O.V., Vivekanandan P. The Warburg effect: insights from the past decade. Pharmacol. Ther. 2013, 137:318-330.